patients with advanced hematologic malignancy Transplantation of allogeneic CD34+ peripheral blood stem cells in

[1]  R. Storb,et al.  Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. , 1996, Blood.

[2]  J. Jackson,et al.  Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation. , 1996, Bone marrow transplantation.

[3]  J. Ferrara,et al.  Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. , 1995, Blood.

[4]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[5]  A. Deisseroth,et al.  Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts , 1995 .

[6]  N. Schmitz,et al.  Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) , 1995, Blood.

[7]  N. Schmitz,et al.  G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1. , 1995, Experimental hematology.

[8]  F. Aversa,et al.  Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. , 1994, Blood.

[9]  E. Bryant,et al.  Y chromosome loss in chronic myeloid leukemia detected in both normal and malignant cells by interphase fluorescence in situ hybridization , 1994, Genes, chromosomes & cancer.

[10]  K. Sullivan,et al.  The management of chronic graft-versus-host disease. , 1994, Blood reviews.

[11]  H. Nieuwenhuis,et al.  Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft [see comments] , 1994 .

[12]  N. Russell,et al.  Risk factors for acute graft-versus-host disease associated with cyclosporine and methotrexate prophylaxis [letter; comment] , 1993 .

[13]  R. Storb,et al.  A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. , 1990, Blood.

[14]  B Budowle,et al.  Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. , 1991, American journal of human genetics.

[15]  K. Sullivan,et al.  Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. , 1989, The New England journal of medicine.

[16]  B. Dupont,et al.  Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. , 1986, Blood.

[17]  K. Sullivan,et al.  Second marrow infusion for poor graft function after allogeneic marrow transplantation. , 1986, Bone marrow transplantation.